What are the targeted drugs for treating small cell lung cancer? There are three categories

At present, no particularly effective targeted drugs have been developed for small cell lung cancer, so some inhibitors that are effective in treating non-small cell cancer are selected in clinical practice to treat small cell lung cancer. Commonly used drugs include Tarceva, Iressa, Avastin, etc. Among them, Avastin has good therapeutic effects and few side effects, but it is much more expensive.

Small cell lung cancer is a special type of lung cancer with a very high degree of malignancy. Small cell lung cancer patients account for about 20% of lung cancer patients. In the early stage of small cell lung cancer, patients only have cough and difficulty breathing. In the late stage, most patients will also have serious symptoms such as hemoptysis and shortness of breath. So what are the targeted drugs for the treatment of small cell lung cancer?
1. Research on targeted drugs for small cell lung cancer <br/>In fact, there are no particularly effective targeted drugs for small cell lung cancer in the world. At present, small cell lung cancer is still treated with chemical drugs, that is, chemotherapy. Among chemical drugs, there are three with good clinical effects, namely: carboplatin, cisplatin, and etoposide. Because of the particularity and complexity of the treatment of small cell lung cancer, it often requires the professional judgment of doctors to select drugs.
2. Inhibitors for the treatment of small cell lung cancer <br/>In clinical practice, many doctors choose to use epidermal growth factor inhibitors to act on tumors to treat patients. Among them, the more common ones suitable for lung cancer patients are Tarceva and Iressa. Tarceva and Iressa are both molecular targeted therapeutic drugs for the treatment of lung cancer. They are inhibitors that can inhibit epidermal growth factor. Both of them are targeted therapeutic drugs for non-small cell tumors and have certain effects on small cell lung cancer. Regardless of the type of drug, it must ultimately be used under the professional guidance of a doctor and should not be used indiscriminately.
3. Treatment with anti-angiogenic inhibitors <br/>Anti-angiogenic inhibitors also have a certain therapeutic effect on small cell lung cancer. At this time, you can choose to use Avastin, which is currently the most advanced targeted drug for the treatment of non-small cell lung cancer. It can actively identify cancer cells and kill them directly without damaging normal cells. Avastin is currently a better drug for the treatment of cancer and has fewer side effects. Therefore, the price of Avastin will be more expensive.